import{j as e}from"./ui-DK5CeS2f.js";import{r as S,b as w}from"./router-aUvmBcd_.js";import{g as E,s as A,e as q,d as M,a0 as C,i as R,o as O,j as V,H as F,B,T as $,ap as H,Z as z,U as G,C as L,a9 as U,a as W}from"./utils-D2RFhntI.js";import"./vendor-DeqkGhWy.js";const f=({children:i,className:o=""})=>e.jsx("div",{className:`bg-white dark:bg-slate-800 rounded-lg shadow-sm border border-gray-200 dark:border-slate-700 ${o}`,children:i}),j=({children:i})=>e.jsx("div",{className:"p-6 pb-4",children:i}),v=({children:i})=>e.jsx("div",{className:"p-6 pt-0",children:i}),b=({children:i})=>e.jsx("h3",{className:"text-lg font-semibold text-gray-900 dark:text-gray-100",children:i}),Q=({children:i,onClick:o,variant:d="default",size:x="default",className:n=""})=>{const P="inline-flex items-center justify-center rounded-md font-medium transition-colors focus-visible:outline-none focus-visible:ring-2 focus-visible:ring-ring focus-visible:ring-offset-2 disabled:opacity-50 disabled:pointer-events-none ring-offset-background",N=d==="outline"?"border border-input bg-background hover:bg-accent hover:text-accent-foreground":"bg-primary text-primary-foreground hover:bg-primary/90",k=x==="sm"?"h-9 px-3 text-sm":"h-10 px-4 py-2";return e.jsx("button",{onClick:o,className:`${P} ${N} ${k} ${n}`,children:i})},Z=({defaultValue:i,max:o,step:d,onValueChange:x,className:n=""})=>{const[P,N]=S.useState(i[0]),k=u=>{const h=parseInt(u.target.value);N(h),x([h])};return e.jsxs("div",{className:`relative ${n}`,children:[e.jsx("input",{type:"range",min:"0",max:o,step:d,value:P,onChange:k,className:"w-full h-2 bg-gray-200 rounded-lg appearance-none cursor-pointer dark:bg-gray-700 slider"}),e.jsx("div",{className:"flex justify-between text-xs text-gray-500 mt-1",children:Array.from({length:o+1},(u,h)=>e.jsx("span",{children:h},h))})]})},l=({children:i,htmlFor:o,className:d=""})=>e.jsx("label",{htmlFor:o,className:`text-sm font-medium leading-none peer-disabled:cursor-not-allowed peer-disabled:opacity-70 ${d}`,children:i}),I=({children:i,value:o,onValueChange:d,className:x=""})=>e.jsx("div",{className:x,role:"radiogroup",children:w.Children.map(i,n=>w.cloneElement(n,{selectedValue:o,onValueChange:d}))}),g=({value:i,id:o,selectedValue:d,onValueChange:x})=>e.jsx("input",{type:"radio",id:o,value:i,checked:d===i,onChange:()=>x(i),className:"w-4 h-4 text-blue-600 bg-gray-100 border-gray-300 focus:ring-blue-500 dark:focus:ring-blue-600 dark:ring-offset-gray-800 focus:ring-2 dark:bg-gray-700 dark:border-gray-600"}),K={assessment:{id:"assessment",title:"Comprehensive Pain Assessment",severity:"assessment",icon:R,content:["Conduct comprehensive pain history using PQRST method: Provocation/Palliation, Quality, Region/Radiation, Severity, Timing","Assess functional impact on Activities of Daily Living (ADLs), sleep quality, mood, appetite, and social interactions","Evaluate psychosocial factors: anxiety, depression, coping mechanisms, spiritual beliefs, cultural background, financial concerns","Perform focused physical examination to identify potential pain generators and neurological deficits","Review previous pain treatments, their effectiveness, side effects, and patient preferences"],tools:["Numeric Rating Scale (NRS 0-10) - Most commonly used","Visual Analog Scale (VAS) - For patients who can use visual markers","Wong-Baker FACES Scale - For children or cognitively impaired","Edmonton Symptom Assessment System (ESAS) - Comprehensive symptom assessment","Pain Diary/Log - For tracking patterns and triggers"],painTypes:[{type:"Nociceptive - Somatic",description:"Sharp, localized pain (e.g., bone metastases)",example:"Aching, stabbing, throbbing"},{type:"Nociceptive - Visceral",description:"Dull, cramping, poorly localized (e.g., liver capsule distension)",example:"Deep, cramping, pressure-like"},{type:"Neuropathic",description:"Burning, electric, shooting pain from nerve damage",example:"Post-chemotherapy neuropathy, diabetic neuropathy"},{type:"Mixed Pain",description:"Combination of nociceptive and neuropathic",example:"Common in advanced cancer"},{type:"Nociplastic",description:"Pain without clear tissue damage or nerve injury",example:"Fibromyalgia-like pain"},{type:"Total Pain",description:"Integration of physical, emotional, spiritual, and social suffering",example:"Holistic approach in palliative care"}]},mild:{id:"mild",title:"Mild Pain Management (NRS 1-3)",severity:"mild",icon:C,whoStep:"Step 1",primaryApproach:"Non-Opioid Analgesics ± Adjuvants",medications:[{name:"Acetaminophen (Paracetamol)",dosing:"500-1000mg every 6 hours (max 3g/day in palliative care)",notes:"Liver-safe alternative, monitor LFTs with prolonged use",contraindications:"Severe liver disease",route:"PO or IV"},{name:"NSAIDs",examples:"Ibuprofen 400-600mg q6h, Naproxen 250-500mg q12h, Celecoxib 100-200mg q12h",notes:"Effective for bone, soft tissue, and inflammatory pain",contraindications:"GI bleeding risk, renal impairment, heart failure",monitoring:"Consider GI protection (PPI), monitor renal function and BP"}],adjuvants:["Topical lidocaine for localized neuropathic pain","Low-dose tricyclic antidepressants if neuropathic component suspected","Gabapentinoids for neuropathic features"],nonPharmacological:["Heat/cold application for localized pain","Positioning and supportive devices (pillows, braces)","Gentle stretching and range-of-motion exercises","Distraction techniques (music, reading, conversation)","Relaxation techniques (deep breathing, progressive muscle relaxation)","TENS (Transcutaneous Electrical Nerve Stimulation)","Physical therapy and massage","Acupuncture"],redFlags:["Pain persisting >1-2 weeks despite appropriate measures","New neurological symptoms or deficits","Pain intensity disproportionate to apparent cause","Signs of systemic illness or infection"],clinicalPearls:["Ensure regular dosing of acetaminophen/NSAIDs if pain is constant rather than PRN","Re-evaluate underlying diagnosis if pain doesn't respond as expected","Consider combination therapy early for better efficacy"]},moderate:{id:"moderate",title:"Moderate Pain Management (NRS 4-6)",severity:"moderate",icon:C,whoStep:"Step 2",primaryApproach:"Weak Opioids + Non-Opioids ± Adjuvants",medications:[{name:"Tramadol",dosing:"50-100mg every 6 hours (max 400mg/day)",notes:"Dual mechanism: opioid and monoamine reuptake inhibition",contraindications:"Seizure disorder, MAOIs",sideEffects:"Nausea, dizziness, constipation, serotonin syndrome risk"},{name:"Codeine combinations",dosing:"30-60mg codeine every 4-6 hours",notes:"Often combined with acetaminophen or ibuprofen",contraindications:"CYP2D6 poor metabolizers, respiratory depression risk",sideEffects:"Constipation, nausea, sedation"}],continuedTherapies:["Maintain regular dosing of acetaminophen if no contraindications","Continue appropriate NSAIDs with GI protection if indicated","Optimize adjuvant medications based on pain characteristics"],adjuvantFocus:["Gabapentin 100-300mg TID, titrate up to 1800mg/day for neuropathic pain","Pregabalin 75mg BID, titrate up to 300mg BID for neuropathic pain","Nortriptyline 10-25mg at bedtime, titrate up to 75mg for neuropathic pain","Duloxetine 30-60mg daily for diabetic neuropathy or fibromyalgia"],nonPharmacological:["Continue and intensify mild pain strategies","Structured physical therapy and occupational therapy","Psychological support and counseling","Cognitive Behavioral Therapy (CBT) for pain management","Acupuncture or acupressure","Mindfulness-based stress reduction"],sideEffectManagement:["Prophylactic laxative regimen with regular opioid use","Antiemetics for opioid-induced nausea","Monitor for sedation and cognitive effects"],redFlags:["Rapid pain escalation requiring frequent dose increases","Opioid side effects limiting further titration","Development of tolerance without pain improvement","Signs of infection or inflammation at pain site","Psychological distress significantly impacting function"],clinicalPearls:["Consider adjuvant therapy early if neuropathic features are present","Evaluate for opioid rotation if side effects are problematic","Assess psychosocial factors contributing to total pain experience"]},severe:{id:"severe",title:"Severe Pain Management (NRS 7-10)",severity:"severe",icon:C,whoStep:"Step 3",primaryApproach:"Strong Opioids + Non-Opioids ± Adjuvants",strongOpioids:[{name:"Morphine",startingDose:"5-10mg PO q4h or 2-4mg IV/SC q2-4h",notes:"Gold standard, multiple formulations available",contraindications:"Severe renal impairment (accumulation of metabolites)",conversions:"PO:IV ratio 3:1",routes:"Oral, IV, SC"},{name:"Oxycodone",startingDose:"5mg PO q4-6h",notes:"Better tolerated in renal impairment than morphine",contraindications:"Severe respiratory depression",conversions:"1.5x more potent than morphine PO",routes:"Oral, IV"},{name:"Hydromorphone",startingDose:"2mg PO q4-6h or 0.5mg IV/SC q2-4h",notes:"Highly potent, useful in renal dysfunction",contraindications:"Severe respiratory depression",conversions:"PO:IV ratio 5:1, 4x more potent than morphine PO",routes:"Oral, IV, SC"},{name:"Fentanyl",application:"Transdermal patch for stable chronic pain",notes:"Only for opioid-tolerant patients, 72-hour duration",contraindications:"Acute pain, opioid-naive patients",conversions:"25mcg/h patch ≈ 60-90mg morphine PO/day",routes:"Transdermal, IV"},{name:"Methadone",notes:"NMDA receptor antagonist, good for neuropathic pain",specialConsiderations:"Complex pharmacokinetics, QT prolongation risk, requires specialist consultation",conversions:"Variable ratio depending on previous opioid dose",routes:"Oral"},{name:"Buprenorphine",notes:"Partial agonist, ceiling effect for respiratory depression",specialConsiderations:"Good for patients with renal impairment",routes:"Transdermal, Sublingual"}],titrationPrinciples:["Start low and titrate rapidly based on frequent reassessment","Breakthrough doses: 10-20% of total 24-hour dose every 1-2 hours PRN","Reassess pain and adjust every 24-48 hours during titration phase","When switching opioids, reduce dose by 25-50% for incomplete cross-tolerance","In palliative care, acceptable to start directly at Step 3 for severe/rapidly escalating pain"],multimodalApproach:["Continue acetaminophen if no contraindications","Add appropriate adjuvants based on pain mechanism","Consider corticosteroids for bone metastases or visceral edema","Optimize non-pharmacological interventions"],advancedInterventions:["Nerve blocks (celiac plexus, sympathetic blocks)","Epidural or intrathecal analgesia","Spinal cord stimulation","Radiotherapy for bone metastases","Palliative surgical procedures","Ketamine infusion for refractory neuropathic pain","Opioid rotation for side effects or tolerance"],sideEffectManagement:["Mandatory prophylactic bowel regimen (stimulant + softener) from day one","Antiemetics for nausea (ondansetron, metoclopramide, haloperidol)","Monitor for sedation and respiratory depression","Manage delirium with low-dose antipsychotics if needed","Consider psychostimulants for persistent sedation"],redFlags:["Uncontrolled pain despite aggressive opioid titration","Severe opioid toxicity (respiratory depression, myoclonus, severe sedation)","Suspected opioid-induced hyperalgesia","New or worsening neurological deficits","Sudden complete cessation of pain (potential catastrophic event)"],specialistReferral:["Palliative Care consultation strongly recommended","Pain Medicine specialist for interventional procedures","Psychiatry/Psychology for complex psychosocial factors","Spiritual care for existential distress"]}},Y=[{drug:"Morphine",route:"PO",dose:"30 mg",equivalency:"Standard reference",potency:"1x"},{drug:"Morphine",route:"IV/SC",dose:"10 mg",equivalency:"30 mg PO morphine",potency:"3x"},{drug:"Oxycodone",route:"PO",dose:"20 mg",equivalency:"30 mg PO morphine",potency:"1.5x"},{drug:"Hydromorphone",route:"PO",dose:"7.5 mg",equivalency:"30 mg PO morphine",potency:"4x"},{drug:"Hydromorphone",route:"IV/SC",dose:"1.5 mg",equivalency:"30 mg PO morphine",potency:"20x"},{drug:"Fentanyl",route:"IV",dose:"0.1 mg (100 mcg)",equivalency:"30 mg PO morphine",potency:"100x"},{drug:"Fentanyl Patch",route:"TD",dose:"25 mcg/h",equivalency:"60-90mg morphine PO/day",potency:"Variable"},{drug:"Methadone",route:"PO",dose:"Variable*",equivalency:"Requires specialist calculation",potency:"Variable"}],_=[{category:"Neuropathic Pain",medications:[{name:"Gabapentin",dosing:"100-300mg TID, titrate to 1800mg/day",notes:"Adjust for renal function"},{name:"Pregabalin",dosing:"75mg BID, titrate to 300mg BID",notes:"More predictable pharmacokinetics"},{name:"Nortriptyline",dosing:"10-25mg HS, titrate to 75mg",notes:"Anticholinergic effects"},{name:"Duloxetine",dosing:"30-60mg daily",notes:"Good for diabetic neuropathy"}]},{category:"Bone Pain",medications:[{name:"Dexamethasone",dosing:"4-8mg daily",notes:"For bone mets, visceral edema, CNS pressure"},{name:"Zoledronic acid",dosing:"4mg IV monthly",notes:"Bisphosphonate for bone metastases"},{name:"Denosumab",dosing:"120mg SC monthly",notes:"Monoclonal antibody for bone mets"}]},{category:"Visceral Pain",medications:[{name:"Hyoscine butylbromide",dosing:"20mg TID-QID",notes:"Antispasmodic for visceral cramping"},{name:"Octreotide",dosing:"100-200mcg SC TID",notes:"For malignant bowel obstruction"}]}],J=[{category:"Physical",interventions:["Physical therapy and occupational therapy","Massage therapy","Acupuncture and acupressure","TENS (Transcutaneous Electrical Nerve Stimulation)","Heat and cold therapy","Positioning and supportive devices"]},{category:"Psychological",interventions:["Cognitive Behavioral Therapy (CBT)","Relaxation training and deep breathing","Mindfulness-based stress reduction","Distraction techniques","Coping skills training","Biofeedback"]},{category:"Social and Spiritual",interventions:["Family counseling and support","Chaplain and spiritual care","Support groups","Cultural considerations","Financial counseling","Advanced care planning"]}],ie=()=>{const[i,o]=S.useState(0),[d,x]=S.useState(null),[n,P]=S.useState({}),[N,k]=S.useState({type:void 0,location:[],duration:void 0,pattern:void 0}),u=a=>a===0?"assessment":a>=1&&a<=3?"mild":a>=4&&a<=6?"moderate":a>=7&&a<=10?"severe":"assessment",h=a=>{switch(a){case"mild":return"text-green-600";case"moderate":return"text-yellow-600";case"severe":return"text-red-600";default:return"text-blue-600"}},T=a=>{switch(a){case"mild":return"border-l-4 border-green-500";case"moderate":return"border-l-4 border-yellow-500";case"severe":return"border-l-4 border-red-500";default:return"border-l-4 border-blue-500"}},D=a=>{o(a[0]);const t=u(a[0]);x(t)},m=a=>{P(t=>({...t,[a]:!t[a]}))},y=({title:a,children:t,icon:p,isExpanded:c,onToggle:s})=>e.jsxs("div",{className:"border border-gray-200 dark:border-slate-700 rounded-lg overflow-hidden",children:[e.jsxs("button",{onClick:s,className:"w-full p-4 bg-gray-50 dark:bg-slate-700 hover:bg-gray-100 dark:hover:bg-slate-600 transition-colors flex items-center justify-between",children:[e.jsxs("div",{className:"flex items-center gap-3",children:[e.jsx(p,{className:"h-5 w-5 text-indigo-600"}),e.jsx("span",{className:"font-medium text-gray-900 dark:text-gray-100",children:a})]}),c?e.jsx(U,{className:"h-5 w-5"}):e.jsx(W,{className:"h-5 w-5"})]}),c&&e.jsx("div",{className:"p-4 bg-white dark:bg-slate-800",children:t})]});return e.jsxs("div",{className:"max-w-7xl mx-auto p-6 space-y-8",children:[e.jsxs("div",{className:"text-center mb-8",children:[e.jsx("h1",{className:"text-3xl font-bold text-gray-900 dark:text-gray-100 mb-2",children:"Palliative Care Pain Management"}),e.jsx("p",{className:"text-gray-600 dark:text-gray-400 max-w-2xl mx-auto",children:"Comprehensive approach to pain assessment and management based on WHO guidelines and evidence-based practices for advanced illness"})]}),e.jsxs(f,{className:"mb-8",children:[e.jsx(j,{children:e.jsxs(b,{className:"flex items-center gap-2",children:[e.jsx(E,{className:"h-5 w-5 text-indigo-600"}),"Pain Score Assessment"]})}),e.jsx(v,{children:e.jsxs("div",{className:"space-y-6",children:[e.jsxs("div",{children:[e.jsx(l,{className:"text-base font-medium mb-4 block",children:"Current Pain Level (0-10 Scale)"}),e.jsx(Z,{defaultValue:[i],max:10,step:1,onValueChange:D,className:"mb-4"}),e.jsxs("div",{className:"flex justify-between text-sm text-gray-500 mb-4",children:[e.jsx("span",{children:"No Pain (0)"}),e.jsx("span",{children:"Worst Possible Pain (10)"})]}),e.jsxs("div",{className:"text-center",children:[e.jsx("span",{className:`text-3xl font-bold ${h(u(i))}`,children:i}),e.jsx("span",{className:"text-lg text-gray-500 ml-2",children:"/ 10"}),e.jsx("div",{className:"mt-2",children:e.jsxs("span",{className:"text-sm font-medium text-gray-700 dark:text-gray-300",children:["Classification: ",u(i)==="assessment"?"No Pain":u(i).charAt(0).toUpperCase()+u(i).slice(1)," Pain"]})})]})]}),i>=7&&e.jsx("div",{className:"p-4 bg-red-50 dark:bg-red-900/20 border border-red-200 dark:border-red-800 rounded-lg",children:e.jsxs("div",{className:"flex items-start gap-3",children:[e.jsx(A,{className:"w-5 h-5 text-red-600 flex-shrink-0 mt-0.5"}),e.jsxs("div",{children:[e.jsx("h4",{className:"font-semibold text-red-800 dark:text-red-300",children:"Severe Pain Alert"}),e.jsx("p",{className:"text-sm text-red-700 dark:text-red-400 mt-1",children:"Immediate intervention required. Consider rescue medication, dose adjustment, or specialist consultation. In palliative care, it's acceptable to start directly at WHO Step 3 for severe pain."})]})]})})]})})]}),e.jsxs(f,{children:[e.jsx(j,{children:e.jsxs(b,{className:"flex items-center gap-2",children:[e.jsx(q,{className:"h-5 w-5 text-indigo-600"}),"Pain Characteristics Assessment"]})}),e.jsx(v,{children:e.jsxs("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-6",children:[e.jsxs("div",{children:[e.jsx(l,{className:"text-base font-medium mb-3 block",children:"Pain Type"}),e.jsxs(I,{value:N.type,onValueChange:a=>k(t=>({...t,type:a})),className:"space-y-3",children:[e.jsxs("div",{className:"flex items-center space-x-2",children:[e.jsx(g,{value:"somatic",id:"somatic"}),e.jsx(l,{htmlFor:"somatic",className:"text-sm",children:"Somatic (Sharp, localized)"})]}),e.jsxs("div",{className:"flex items-center space-x-2",children:[e.jsx(g,{value:"visceral",id:"visceral"}),e.jsx(l,{htmlFor:"visceral",className:"text-sm",children:"Visceral (Dull, cramping)"})]}),e.jsxs("div",{className:"flex items-center space-x-2",children:[e.jsx(g,{value:"neuropathic",id:"neuropathic"}),e.jsx(l,{htmlFor:"neuropathic",className:"text-sm",children:"Neuropathic (Burning, electric)"})]}),e.jsxs("div",{className:"flex items-center space-x-2",children:[e.jsx(g,{value:"mixed",id:"mixed"}),e.jsx(l,{htmlFor:"mixed",className:"text-sm",children:"Mixed"})]}),e.jsxs("div",{className:"flex items-center space-x-2",children:[e.jsx(g,{value:"total",id:"total"}),e.jsx(l,{htmlFor:"total",className:"text-sm",children:"Total Pain (Physical + Psychosocial)"})]})]})]}),e.jsxs("div",{children:[e.jsx(l,{className:"text-base font-medium mb-3 block",children:"Pain Pattern"}),e.jsxs(I,{value:N.pattern,onValueChange:a=>k(t=>({...t,pattern:a})),className:"space-y-3",children:[e.jsxs("div",{className:"flex items-center space-x-2",children:[e.jsx(g,{value:"constant",id:"constant"}),e.jsx(l,{htmlFor:"constant",className:"text-sm",children:"Constant"})]}),e.jsxs("div",{className:"flex items-center space-x-2",children:[e.jsx(g,{value:"intermittent",id:"intermittent"}),e.jsx(l,{htmlFor:"intermittent",className:"text-sm",children:"Intermittent"})]}),e.jsxs("div",{className:"flex items-center space-x-2",children:[e.jsx(g,{value:"breakthrough",id:"breakthrough"}),e.jsx(l,{htmlFor:"breakthrough",className:"text-sm",children:"Breakthrough"})]}),e.jsxs("div",{className:"flex items-center space-x-2",children:[e.jsx(g,{value:"incident",id:"incident"}),e.jsx(l,{htmlFor:"incident",className:"text-sm",children:"Incident (Movement-related)"})]})]})]})]})})]}),e.jsxs("div",{className:"space-y-6",children:[e.jsxs("h2",{className:"text-2xl font-bold text-gray-900 dark:text-gray-100 flex items-center gap-3",children:[e.jsx(M,{className:"h-6 w-6 text-indigo-600"}),"Management Protocols"]}),Object.values(K).map(a=>{const t=a.icon,p=d===a.id,c=n[a.id]||p;return e.jsxs(f,{className:`${T(a.severity)} ${c?"":"cursor-pointer hover:shadow-md transition-shadow"}`,children:[e.jsx(j,{onClick:()=>!c&&m(a.id),children:e.jsxs("div",{className:"flex items-center justify-between",children:[e.jsxs("div",{className:"flex items-center gap-3",children:[e.jsx(t,{className:`h-6 w-6 ${h(a.severity)}`}),e.jsxs(b,{className:h(a.severity),children:[a.title," ",a.whoStep&&`(${a.whoStep})`]})]}),e.jsx(Q,{variant:"outline",size:"sm",onClick:s=>{s.stopPropagation(),m(a.id)},children:c?"Collapse":"Expand"})]})}),c&&e.jsxs(v,{className:"space-y-6",children:[a.primaryApproach&&e.jsxs("div",{className:"bg-blue-50 dark:bg-blue-900/20 p-4 rounded-lg",children:[e.jsx("h4",{className:"font-semibold text-blue-800 dark:text-blue-300 mb-2",children:"Primary Approach"}),e.jsx("p",{className:"text-blue-700 dark:text-blue-400",children:a.primaryApproach})]}),a.medications&&e.jsx(y,{title:"Medications",icon:C,isExpanded:n[`${a.id}-meds`],onToggle:()=>m(`${a.id}-meds`),children:e.jsx("div",{className:"space-y-4",children:a.medications.map((s,r)=>e.jsxs("div",{className:"border-b border-gray-200 dark:border-slate-700 pb-4 last:border-0 last:pb-0",children:[e.jsx("h5",{className:"font-medium text-gray-900 dark:text-gray-100",children:s.name}),e.jsxs("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-4 mt-2",children:[e.jsxs("div",{children:[e.jsxs("p",{className:"text-sm text-gray-600 dark:text-gray-400",children:[e.jsx("span",{className:"font-medium",children:"Dosing:"})," ",s.dosing]}),s.examples&&e.jsxs("p",{className:"text-sm text-gray-600 dark:text-gray-400",children:[e.jsx("span",{className:"font-medium",children:"Examples:"})," ",s.examples]})]}),e.jsxs("div",{children:[s.notes&&e.jsxs("p",{className:"text-sm text-gray-600 dark:text-gray-400",children:[e.jsx("span",{className:"font-medium",children:"Notes:"})," ",s.notes]}),s.contraindications&&e.jsxs("p",{className:"text-sm text-gray-600 dark:text-gray-400",children:[e.jsx("span",{className:"font-medium",children:"Contraindications:"})," ",s.contraindications]})]})]})]},r))})}),a.strongOpioids&&e.jsx(y,{title:"Strong Opioids",icon:O,isExpanded:n[`${a.id}-opioids`],onToggle:()=>m(`${a.id}-opioids`),children:e.jsx("div",{className:"space-y-4",children:a.strongOpioids.map((s,r)=>e.jsxs("div",{className:"border-b border-gray-200 dark:border-slate-700 pb-4 last:border-0 last:pb-0",children:[e.jsx("h5",{className:"font-medium text-gray-900 dark:text-gray-100",children:s.name}),e.jsxs("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-4 mt-2",children:[e.jsxs("div",{children:[s.startingDose&&e.jsxs("p",{className:"text-sm text-gray-600 dark:text-gray-400",children:[e.jsx("span",{className:"font-medium",children:"Starting Dose:"})," ",s.startingDose]}),s.application&&e.jsxs("p",{className:"text-sm text-gray-600 dark:text-gray-400",children:[e.jsx("span",{className:"font-medium",children:"Application:"})," ",s.application]}),s.conversions&&e.jsxs("p",{className:"text-sm text-gray-600 dark:text-gray-400",children:[e.jsx("span",{className:"font-medium",children:"Conversions:"})," ",s.conversions]}),s.routes&&e.jsxs("p",{className:"text-sm text-gray-600 dark:text-gray-400",children:[e.jsx("span",{className:"font-medium",children:"Routes:"})," ",s.routes]})]}),e.jsxs("div",{children:[s.notes&&e.jsxs("p",{className:"text-sm text-gray-600 dark:text-gray-400",children:[e.jsx("span",{className:"font-medium",children:"Notes:"})," ",s.notes]}),s.contraindications&&e.jsxs("p",{className:"text-sm text-gray-600 dark:text-gray-400",children:[e.jsx("span",{className:"font-medium",children:"Contraindications:"})," ",s.contraindications]}),s.specialConsiderations&&e.jsxs("p",{className:"text-sm text-gray-600 dark:text-gray-400",children:[e.jsx("span",{className:"font-medium",children:"Special Considerations:"})," ",s.specialConsiderations]})]})]})]},r))})}),a.adjuvants&&e.jsx(y,{title:"Adjuvant Medications",icon:V,isExpanded:n[`${a.id}-adjuvants`],onToggle:()=>m(`${a.id}-adjuvants`),children:e.jsx("ul",{className:"space-y-2 list-disc pl-5",children:a.adjuvants.map((s,r)=>e.jsx("li",{className:"text-sm text-gray-700 dark:text-gray-300",children:s},r))})}),a.nonPharmacological&&e.jsx(y,{title:"Non-Pharmacological Interventions",icon:F,isExpanded:n[`${a.id}-nonpharm`],onToggle:()=>m(`${a.id}-nonpharm`),children:e.jsx("ul",{className:"space-y-2 list-disc pl-5",children:a.nonPharmacological.map((s,r)=>e.jsx("li",{className:"text-sm text-gray-700 dark:text-gray-300",children:s},r))})}),a.redFlags&&e.jsxs("div",{className:"bg-red-50 dark:bg-red-900/20 border border-red-200 dark:border-red-800 rounded-lg p-4",children:[e.jsxs("h4",{className:"font-semibold text-red-800 dark:text-red-300 mb-2 flex items-center gap-2",children:[e.jsx(O,{className:"w-5 h-5"}),"Red Flags and Warnings"]}),e.jsx("ul",{className:"space-y-2 list-disc pl-5 text-red-700 dark:text-red-400",children:a.redFlags.map((s,r)=>e.jsx("li",{className:"text-sm",children:s},r))})]}),a.clinicalPearls&&e.jsxs("div",{className:"bg-blue-50 dark:bg-blue-900/20 border border-blue-200 dark:border-blue-800 rounded-lg p-4",children:[e.jsxs("h4",{className:"font-semibold text-blue-800 dark:text-blue-300 mb-2 flex items-center gap-2",children:[e.jsx(B,{className:"w-5 h-5"}),"Clinical Pearls"]}),e.jsx("ul",{className:"space-y-2 list-disc pl-5 text-blue-700 dark:text-blue-400",children:a.clinicalPearls.map((s,r)=>e.jsx("li",{className:"text-sm",children:s},r))})]}),a.titrationPrinciples&&e.jsx(y,{title:"Titration Principles",icon:$,isExpanded:n[`${a.id}-titration`],onToggle:()=>m(`${a.id}-titration`),children:e.jsx("ul",{className:"space-y-2 list-disc pl-5",children:a.titrationPrinciples.map((s,r)=>e.jsx("li",{className:"text-sm text-gray-700 dark:text-gray-300",children:s},r))})}),a.sideEffectManagement&&e.jsx(y,{title:"Side Effect Management",icon:A,isExpanded:n[`${a.id}-sideeffects`],onToggle:()=>m(`${a.id}-sideeffects`),children:e.jsx("ul",{className:"space-y-2 list-disc pl-5",children:a.sideEffectManagement.map((s,r)=>e.jsx("li",{className:"text-sm text-gray-700 dark:text-gray-300",children:s},r))})})]})]},a.id)})]}),e.jsxs(f,{children:[e.jsx(j,{children:e.jsxs(b,{className:"flex items-center gap-2",children:[e.jsx(H,{className:"h-5 w-5 text-indigo-600"}),"Opioid Equianalgesic Conversion Table"]})}),e.jsxs(v,{children:[e.jsx("div",{className:"overflow-x-auto",children:e.jsxs("table",{className:"min-w-full divide-y divide-gray-200 dark:divide-slate-700",children:[e.jsx("thead",{className:"bg-gray-50 dark:bg-slate-800",children:e.jsxs("tr",{children:[e.jsx("th",{className:"px-6 py-3 text-left text-xs font-medium text-gray-500 dark:text-gray-400 uppercase tracking-wider",children:"Drug"}),e.jsx("th",{className:"px-6 py-3 text-left text-xs font-medium text-gray-500 dark:text-gray-400 uppercase tracking-wider",children:"Route"}),e.jsx("th",{className:"px-6 py-3 text-left text-xs font-medium text-gray-500 dark:text-gray-400 uppercase tracking-wider",children:"Equianalgesic Dose"}),e.jsx("th",{className:"px-6 py-3 text-left text-xs font-medium text-gray-500 dark:text-gray-400 uppercase tracking-wider",children:"Relative Potency"})]})}),e.jsx("tbody",{className:"bg-white dark:bg-slate-800 divide-y divide-gray-200 dark:divide-slate-700",children:Y.map((a,t)=>e.jsxs("tr",{children:[e.jsx("td",{className:"px-6 py-4 whitespace-nowrap text-sm font-medium text-gray-900 dark:text-gray-100",children:a.drug}),e.jsx("td",{className:"px-6 py-4 whitespace-nowrap text-sm text-gray-500 dark:text-gray-400",children:a.route}),e.jsxs("td",{className:"px-6 py-4 whitespace-nowrap text-sm text-gray-500 dark:text-gray-400",children:[a.dose," ",a.equivalency&&`≈ ${a.equivalency}`]}),e.jsx("td",{className:"px-6 py-4 whitespace-nowrap text-sm text-gray-500 dark:text-gray-400",children:a.potency})]},t))})]})}),e.jsx("div",{className:"mt-4 text-sm text-gray-600 dark:text-gray-400",children:e.jsxs("p",{children:[e.jsx("strong",{children:"Note:"})," Methadone has a nonlinear conversion depending on previous opioid exposure. Consult specialist or use conservative conversion ratios and titrate carefully."]})})]})]}),e.jsxs(f,{children:[e.jsx(j,{children:e.jsxs(b,{className:"flex items-center gap-2",children:[e.jsx(z,{className:"h-5 w-5 text-indigo-600"}),"Adjuvant Medications by Pain Type"]})}),e.jsx(v,{children:e.jsx("div",{className:"grid grid-cols-1 md:grid-cols-3 gap-6",children:_.map((a,t)=>e.jsxs("div",{className:"border border-gray-200 dark:border-slate-700 rounded-lg overflow-hidden",children:[e.jsx("div",{className:"bg-gray-50 dark:bg-slate-700 p-4",children:e.jsx("h4",{className:"font-semibold text-gray-900 dark:text-gray-100",children:a.category})}),e.jsx("div",{className:"p-4",children:e.jsx("ul",{className:"space-y-4",children:a.medications.map((p,c)=>e.jsxs("li",{children:[e.jsx("h5",{className:"font-medium text-gray-900 dark:text-gray-100",children:p.name}),e.jsxs("p",{className:"text-sm text-gray-600 dark:text-gray-400",children:[e.jsx("span",{className:"font-medium",children:"Dosing:"})," ",p.dosing]}),p.notes&&e.jsxs("p",{className:"text-sm text-gray-600 dark:text-gray-400",children:[e.jsx("span",{className:"font-medium",children:"Notes:"})," ",p.notes]})]},c))})})]},t))})})]}),e.jsxs(f,{children:[e.jsx(j,{children:e.jsxs(b,{className:"flex items-center gap-2",children:[e.jsx(G,{className:"h-5 w-5 text-indigo-600"}),"Non-Pharmacological Interventions"]})}),e.jsx(v,{children:e.jsx("div",{className:"grid grid-cols-1 md:grid-cols-3 gap-6",children:J.map((a,t)=>e.jsxs("div",{className:"border border-gray-200 dark:border-slate-700 rounded-lg overflow-hidden",children:[e.jsx("div",{className:"bg-gray-50 dark:bg-slate-700 p-4",children:e.jsx("h4",{className:"font-semibold text-gray-900 dark:text-gray-100",children:a.category})}),e.jsx("div",{className:"p-4",children:e.jsx("ul",{className:"space-y-2 list-disc pl-5",children:a.interventions.map((p,c)=>e.jsx("li",{className:"text-sm text-gray-700 dark:text-gray-300",children:p},c))})})]},t))})})]}),e.jsxs(f,{children:[e.jsx(j,{children:e.jsxs(b,{className:"flex items-center gap-2",children:[e.jsx(L,{className:"h-5 w-5 text-indigo-600"}),"End-of-Life Pain Management Considerations"]})}),e.jsx(v,{children:e.jsxs("div",{className:"space-y-4",children:[e.jsxs("div",{className:"p-4 bg-purple-50 dark:bg-purple-900/20 border border-purple-200 dark:border-purple-800 rounded-lg",children:[e.jsx("h4",{className:"font-semibold text-purple-800 dark:text-purple-300 mb-2",children:"Key Principles"}),e.jsxs("ul",{className:"space-y-2 list-disc pl-5 text-purple-700 dark:text-purple-400",children:[e.jsx("li",{children:"Use parenteral routes if oral not tolerated (SC or IV preferred)"}),e.jsx("li",{children:"Continuous opioid infusions (e.g., morphine, hydromorphone) for stable pain control"}),e.jsx("li",{children:"Maintain breakthrough PRN doses (10-20% of total daily dose)"}),e.jsx("li",{children:"Consider palliative sedation for intractable suffering"}),e.jsx("li",{children:"Ensure family education on signs of distress and medication use"})]})]}),e.jsx(y,{title:"Common End-of-Life Medications",icon:C,isExpanded:n["eol-meds"],onToggle:()=>m("eol-meds"),children:e.jsxs("div",{className:"grid grid-cols-1 md:grid-cols-2 gap-4",children:[e.jsxs("div",{children:[e.jsx("h5",{className:"font-medium text-gray-900 dark:text-gray-100",children:"Continuous Infusions"}),e.jsxs("ul",{className:"space-y-2 mt-2",children:[e.jsxs("li",{className:"text-sm text-gray-700 dark:text-gray-300",children:[e.jsx("span",{className:"font-medium",children:"Morphine:"})," 2-4mg SC q2-4h or 10-30mg/24h SC infusion"]}),e.jsxs("li",{className:"text-sm text-gray-700 dark:text-gray-300",children:[e.jsx("span",{className:"font-medium",children:"Hydromorphone:"})," 0.5mg SC q2-4h or 2-4mg/24h SC infusion"]})]})]}),e.jsxs("div",{children:[e.jsx("h5",{className:"font-medium text-gray-900 dark:text-gray-100",children:"Breakthrough Doses"}),e.jsxs("ul",{className:"space-y-2 mt-2",children:[e.jsxs("li",{className:"text-sm text-gray-700 dark:text-gray-300",children:[e.jsx("span",{className:"font-medium",children:"Morphine:"})," 2-4mg SC q1h PRN"]}),e.jsxs("li",{className:"text-sm text-gray-700 dark:text-gray-300",children:[e.jsx("span",{className:"font-medium",children:"Hydromorphone:"})," 0.5mg SC q1h PRN"]})]})]})]})}),e.jsx(y,{title:"Symptom Management",icon:M,isExpanded:n["eol-symptoms"],onToggle:()=>m("eol-symptoms"),children:e.jsxs("div",{className:"space-y-4",children:[e.jsxs("div",{children:[e.jsx("h5",{className:"font-medium text-gray-900 dark:text-gray-100",children:"Respiratory Secretions"}),e.jsxs("p",{className:"text-sm text-gray-700 dark:text-gray-300",children:[e.jsx("span",{className:"font-medium",children:"Glycopyrrolate:"})," 0.2mg SC q4-6h or 0.6-1.2mg/24h SC infusion"]})]}),e.jsxs("div",{children:[e.jsx("h5",{className:"font-medium text-gray-900 dark:text-gray-100",children:"Agitation/Delirium"}),e.jsxs("p",{className:"text-sm text-gray-700 dark:text-gray-300",children:[e.jsx("span",{className:"font-medium",children:"Haloperidol:"})," 0.5-2mg SC q4-6h PRN"]})]}),e.jsxs("div",{children:[e.jsx("h5",{className:"font-medium text-gray-900 dark:text-gray-100",children:"Nausea/Vomiting"}),e.jsxs("p",{className:"text-sm text-gray-700 dark:text-gray-300",children:[e.jsx("span",{className:"font-medium",children:"Metoclopramide:"})," 10mg SC q6h or 40-60mg/24h SC infusion"]})]})]})})]})})]})]})};export{ie as default};
